1/1

13 files

Efficacy and safety of pembrolizumab combined with albumin-bound paclitaxel and nedaplatin for advanced esophageal squamous cell carcinoma

figure

posted on 2024-01-10, 08:59 authored by Fang Yan, Longpei Chen, Mingzhen Ying, Jie Li, Qiang Fu

Supplementary figures 1-7

History

Usage metrics

Categories

Humoural immunology and immunochemistry

Keywords

ab-Pac albumin-bound paclitaxel ESCC esophageal squamous cell carcinoma immunotherapy NDP nedaplatin PBL pembrolizumab

Licence

CC BY-NC-ND 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC